When a Seizure Strikes, Are Your Patients Prepared?
A complete Seizure Preparedness Plan can help your patients live life with less fear and uncertainty.
Download
a plan now.
Update: 20 mg Syringe Has Changed
Pharmacists will no longer be able to dispense a 10mg dose in a 20mg
syringe. Rather, if the prescription calls for 10mg dose, you will
need to provide your patient with a 10mg syringe set at the maximum
dose of 10mg.
Full details.
Tips For Counseling Your Patients
To help ensure patients receive the correct dose and are able to administer
DIASTAT® AcuDial™ (diazepam rectal gel) with confidence, please
review the follow 3 steps:
-
Check that does has been locked BEFORE leaving pharmacy and
inspect tip for cracks:
- Remove DIASTAT AcuDial from the case
- Confirm that the prescribed dose is visible in the display window
and, if known, is correct
- Make sure that the green “Ready” band is visible
- Without completely removing the cap, inspect the syringe for
cracked tips
- Then, return the DIASTAT AcuDial to the case
- If the prescription is for a child, ensure that the smaller rectal
tip size was given
- Because the consumer will receive 2 DIASTAT AcuDial delivery systems
as part of the Twin Pack, be sure to check both
-
Review Administration Instructions
It is also important to discuss the proper administration and disposal techniques with customers and caregivers.
Print Administration and Disposal Instructions Sheet [Developer: Launch PDF Example 6 in new window]
-
Review Proper Disposal Technique
Because there may be unused drug left in the DIASTAT AcuDial delivery system, it is important to discuss the disposal instructions.
- Do not reuse DIASTAT AcuDial
- Discard DIASTAT AcuDial in a safe place away from children
Print Administration and Disposal
Instructions Sheet [Developer: Launch PDF Example 6 in new window]
If you have any questions or would like to schedule a visit from a Valeant Sales Representative, please call 1-877-361-2719.
IMPORTANT SAFETY INFORMATION
DIASTAT
® AcuDial™ (diazepam rectal gel) is a gel formulation
of diazepam intended for rectal administration in the management of selected,
refractory patients with epilepsy, on stable regimens of AEDs, who require
intermittent use of diazepam to control bouts of increased seizure activity
for patients 2 years and older.
In clinical trials with DIASTAT
®, the most frequent side effect
was somnolence (23%). Less frequent adverse events reported were dizziness,
headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination,
asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see
full
DIASTAT AcuDial Prescribing Information.